Clinical Trial Update: Propranolol in Capillary Hemangiomas [Phase 2, Phase 3]

View source ↗

Summary

Update on a Phase 2/3 trial of Propranolol for capillary hemangioma; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Capillary Hemangioma

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Hemangioma, Capillary | Phase 2, Phase 3 | Status: TERMINATED